Siegel D, Murphy C, Wangsness K, Perry A, Smith I. Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. J of Skin [Internet]. 2022 Mar. 4 [cited 2024 Jul. 3];6(2):109-21. Available from: https://jofskin.org/33014/index.php/skin/article/view/1475